Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWater Intel. Regulatory News (WATR)

Share Price Information for Water Intel. (WATR)

Share Price is delayed by 15 minutes
Get Live Data
247.50    -4.00 (-1.64%)
Bid:
240.00
Ask:
255.00
Spread: 15.00 (6.25%)
Market Cap: £40.41m
WATR Live PriceLast checked at - London Stock Exchange

Intraday Water Intel. Share Chart

Trading Update

5 Dec 2023 07:00

RNS Number : 6417V
Water Intelligence PLC
05 December 2023
 

 

Water Intelligence plc 

 Trading Update: On-Track During the First Ten Months

Water Intelligence plc (AIM: WATR.L) (the "Group" or "Water Intelligence"), a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions for both potable and non-potable water is pleased to provide its Trading update for the ten month period ended 31 October 2023. 

Update on Growth Strategy

· Market demand for precision water and wastewater infrastructure solutions continues to grow globally. During Q3, the Group renewed multi-year municipal contracts in Australia and executed new municipal contracts in the EU to grow the Group's presence internationally

· In terms of execution, the Group will be completing in the US, during Q1 2024, its implementation of Salesforce and related applications for its scheduling, delivery and payments system to achieve operating scaleability and efficiencies across corporate and franchise locations. Such enhanced execution functionalities are expected to lead to gaining additional national insurance contracts during Q4 for execution during 2024

· Both EBITDA and PBT margins have improved despite higher inflation and higher interest rates

· In terms of investments to support growth, in October the Group launched a new training, product assembly and R&D facility in Connecticut to supply more trained technicians and specialized equipment to meet market demand for solutions; the facility will also be a showcase to support the sale of new American Leak Detection franchises for which there is current demand. 

Financial Highlights for the ten month period ended 31 October 2023

· Revenue increased by 6% to $64.4 million (2022: $60.9 million)

o Franchise royalty flat $5.8 million (2022: $5.8 million)

o Franchise-related activities (franchise sales, equipment sales, business-to-business channels) increased by 9% to $9.7 million (2022: $8.9 million)

§ Insurance business-to-business channel grew by 9% to $9.1 million (2022: $8.4 million)

o US Corporate sales increased by 5% to $42.6 million (2022: $40.4 million)

o International Corporate sales rose by 10% to $6.4 million (2022: $5.8 million)

· Statutory PBT grew by 11% to $6.8 million (2022: $6.1 million)

· Adjusted PBT (before non-cash expenses of amortization and share-based payments; and non-core costs) increased by 14% to $8.7 million (2022: $7.7 million)

· Statutory EBITDA rose by 6% to $11.3 million (2022: $10.7 million)

· Adjusted EBITDA (before non-cash share-based payments; and non-core costs) rose by 9% to $12.6 million (2022: $11.6 million)

· Adjusted PBT and Adjusted EBITDA Margins improve

o Adjusted PBT margins improve to 14% (2022: 13%)

o Adjusted EBITDA margins improve to 20% (2022: 19%)

· Balance sheet strong at 31 October 2023

o Cash and equivalents at $17.2 million

o Bank Debt of $15.3 million and Deferred Acquisition Payments of $8.6 million (combined $23.9 million) with payments spread through 2027 at a fixed interest rate of approximately 5%

o Net Debt (including bank debt and deferred consideration) to Statutory EBITDA TTM ratio: 0.58 (low degree of leverage affording significant financial capacity for acquisitions)

Commenting on the Group's performance, Executive Chairman, Dr. Patrick DeSouza remarked:

"From an operational perspective, the Group has adjusted well during 2023 to inflationary and higher interest rate headwinds. We are achieving profit growth and increasing margins, as well as making investments for accelerating sales growth in 2024 and beyond. Moreover, we will be completing our Salesforce implementation during Q1 2024 which will enable us to accelerate the growth of our national sales channels. To meet increased market demand, we are launching an advanced training centre in Connecticut. Importantly, we have maintained a strong balance sheet and have additional financial capacity to invest in organic growth and to execute accretive acquisitions to fuel added revenue and profits.

We remain confident in our long-term growth prospects and our ability to continue delivering value for both our franchise and corporate stakeholders. In delivering on our growth plan, we appreciate the on-going support of our shareholders." 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Enquiries:

Water Intelligence plc

Patrick DeSouza, Executive Chairman

Tel: +1 203 654 5426

RBC Capital Markets - Joint Broker Rupert Walford

Elizabeth Evans

Daniel Saveski

 

Tel: +44 (0)20 7653 4000

WH Ireland Limited - NOMAD & Joint Broker

Tel: +44 (0)20 7220 1666

Hugh Morgan

James Bavister

Dowgate Capital Ltd - Joint Broker Stephen Norcross

Tel: +44 (0)20 3903 7715

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKQBKBBDBQBK
Date   Source Headline
29th May 20267:00 amRNSTotal Voting Rights
19th May 20267:00 amRNSQ1 Trading Update
5th May 20267:00 amRNSTransaction in Own Shares & Total Voting Rights
1st May 20267:01 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares & Total Voting Rights
29th Apr 20267:00 amRNSTransaction in Own Shares & Total Voting Rights
27th Apr 202610:24 amRNSTransaction in Own Shares & Total Voting Rights
22nd Apr 20269:47 amRNSTransaction in Own Shares & Total Voting Rights
10th Apr 20267:00 amRNSTransaction in Own Shares & Total Voting Rights
9th Apr 20269:15 amRNSTransaction in Own Shares & Total Voting Rights
8th Apr 202610:16 amRNSTransaction in Own Shares & Total Voting Rights
7th Apr 20267:00 amRNSTransaction in Own Shares & Total Voting Rights
31st Mar 20267:01 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares & Total Voting Rights
30th Mar 202611:02 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20269:19 amRNSTransaction in Own Shares & Total Voting Rights
26th Mar 202612:10 pmRNSTransaction in Own Shares & Total Voting Rights
25th Mar 20267:00 amRNSIssue of Options
24th Mar 202610:12 amRNSTransaction in Own Shares & Total Voting Rights
19th Mar 20267:00 amRNSTransaction in Own Shares & Total Voting Rights
18th Mar 20269:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Mar 20267:00 amRNS2025 Full Year Trading Update & Board Change
17th Mar 20267:00 amRNS2025 Full Year Trading Update & Board Change
2nd Mar 20267:00 amRNSPreferred Partnership Agreement with BlueBot
19th Jan 202610:09 amRNSHolding(s) in Company
2nd Jan 202611:13 amRNSResult of AGM
9th Dec 20257:00 amRNSNotice of AGM, Share Buyback & Rule 9 Waiver
1st Dec 20257:00 amRNSTotal Voting Rights
17th Nov 202510:05 amRNSTransaction in Own Shares and Total Voting Rights
6th Nov 20258:48 amRNSTransaction in Own Shares & Total Voting Rights
5th Nov 20257:00 amRNSNine Months Trading Update
31st Oct 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSNotice of Nine-Month Trading Update
24th Oct 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
23rd Oct 20258:21 amRNSTransaction in Own Shares & Total Voting Rights
22nd Oct 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
21st Oct 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
20th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20252:05 pmRNSTransaction in Own Shares and Total Voting Rights
16th Oct 20259:31 amRNSTransaction in Own Shares & Total Voting Rights
15th Oct 20252:11 pmRNSTransaction in Own Shares & Total Voting Rights
13th Oct 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
10th Oct 20258:38 amRNSTransaction in Own Shares & Total Voting Rights
9th Oct 20258:44 amRNSTransaction in Own Shares & Total Voting Rights
6th Oct 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Oct 20251:36 pmRNSTransaction in Own Shares & Total Voting Rights
2nd Oct 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
1st Oct 20257:01 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSIssue of Options, PDMR Dealings & Share Buyback
30th Sep 20257:00 amRNSTransaction in Own Shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.